BJP Mental Health Guidelines from NICE
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silverstone, T.
Right arrow Articles by Goodall, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silverstone, T.
Right arrow Articles by Goodall, E.

The British Journal of Psychiatry 153: 214-217 (1988)
© 1988 The Royal College of Psychiatrists

Prevalence of obesity in patients receiving depot antipsychotics

T Silverstone, G Smith and E Goodall
Medical College, St Bartholomew's Hospital, London.

Antipsychotic drugs have long been noted to cause pronounced weight gain, and drug-induced obesity can assume major clinical importance in long-term medication in the management of chronic schizophrenia. Obesity is associated with increased morbidity and may reduce compliance, leading to a return of psychotic symptoms. In a survey of 226 patients attending depot neuroleptic clinics in one inner London borough, it was found that the prevalence of clinically relevant obesity was four times that in the general population.


This article has been cited by other articles:


Home page
 Psychiatr. Serv.Home page
M.-K. Wu, C.-K. Wang, Y.-M. Bai, C.-Y. Huang, and S.-D. Lee
Outcomes of Obese, Clozapine-Treated Inpatients With Schizophrenia Placed on a Six-Month Diet and Physical Activity Program
Psychiatr Serv, April 1, 2007; 58(4): 544 - 550.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
M. Peet
Diet, diabetes and schizophrenia: review and hypothesis
The British Journal of Psychiatry, April 1, 2004; 184(47): s102 - s105.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
D. M. LAWRENCE, C. D'A. J. HOLMAN, A. V. JABLENSKY, and M. S. T. HOBBS
Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980-1998
The British Journal of Psychiatry, January 2, 2003; 182(1): 31 - 36.
[Abstract] [Full Text] [PDF]

Home page
 Psychiatr. Bull.Home page
P. Bebbington
Choosing antipsychotic drugs in schizophrenia: A personal view
Psychiatr. Bull., August 1, 2001; 25(8): 284 - 286.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1988 The Royal College of Psychiatrists.